KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) Depreciation Expense (2016 - 2025)

Historic Depreciation Expense for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $6.8 million.

  • Medpace Holdings' Depreciation Expense fell 481.98% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 127.01%. This contributed to the annual value of $27.8 million for FY2024, which is 1524.72% up from last year.
  • As of Q3 2025, Medpace Holdings' Depreciation Expense stood at $6.8 million, which was down 481.98% from $6.8 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Depreciation Expense high stood at $7.2 million for Q3 2024, and its period low was $3.8 million during Q1 2021.
  • For the 5-year period, Medpace Holdings' Depreciation Expense averaged around $5.6 million, with its median value being $6.0 million (2023).
  • In the last 5 years, Medpace Holdings' Depreciation Expense surged by 5540.15% in 2021 and then plummeted by 481.98% in 2025.
  • Over the past 5 years, Medpace Holdings' Depreciation Expense (Quarter) stood at $4.2 million in 2021, then increased by 21.17% to $5.1 million in 2022, then rose by 26.62% to $6.4 million in 2023, then increased by 11.26% to $7.1 million in 2024, then decreased by 4.65% to $6.8 million in 2025.
  • Its Depreciation Expense stands at $6.8 million for Q3 2025, versus $6.8 million for Q2 2025 and $6.7 million for Q1 2025.